0001209191-18-016878.txt : 20180305
0001209191-18-016878.hdr.sgml : 20180305
20180305184536
ACCESSION NUMBER: 0001209191-18-016878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baracchini Edgardo Jr
CENTRAL INDEX KEY: 0001291972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36182
FILM NUMBER: 18668070
MAIL ADDRESS:
STREET 1: C/O METABASIS THERAPEUTICS
STREET 2: 9390 TOWNE CENTRE DRIVE, BLDG. 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xencor Inc
CENTRAL INDEX KEY: 0001326732
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201622502
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 WEST LEMON AVE
CITY: MONROVIA
STATE: CA
ZIP: 91016
BUSINESS PHONE: 626-305-5900
MAIL ADDRESS:
STREET 1: 111 WEST LEMON AVE
CITY: MONROVIA
STATE: CA
ZIP: 91016
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-02
0
0001326732
Xencor Inc
XNCR
0001291972
Baracchini Edgardo Jr
C/O XENCOR, INC.
111 WEST LEMON AVENUE
MONROVIA
CA
91016
0
1
0
0
Chief Business Officer
Common Stock
2018-03-02
4
M
0
10000
0.59
A
10000
D
Common Stock
2018-03-02
4
S
0
10000
29.5966
D
0
D
Common Stock
2018-03-05
4
M
0
10000
0.59
A
10000
D
Common Stock
2018-03-05
4
S
0
10000
29.584
D
0
D
Stock Option (right to buy)
0.59
2018-03-02
4
M
0
10000
0.00
D
2020-01-17
Common Stock
10000
91809
D
Stock Option (right to buy)
0.59
2018-03-05
4
M
0
10000
0.00
D
2020-01-17
Common Stock
10000
81809
D
Reported transaction occured pursuant to a Rule 10b5-1 Plan adopted September 14, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.20 to $29.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.825, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The stock option is fully vested and exercisable.
/s/ Edgardo Baracchini, Jr.
2018-03-05